Andira Medicine
Andira Medicine reported $120,000 raised in an SEC Form D filed on 2026-10-09. State of the filing: British Columbia, Canada.
- Industry
- Other
- Location
- British Columbia, Canada
About
Andira Medicine appears in Section 3 of the Raise Track Update of 2026-10-13, which lists new SEC Form D filings. The filing reports $120,000 raised and gives British Columbia, Canada as the state. The industry on the filing is Other. Related persons named on the filing: Dana Lambert, Ethan Russo and Michael Wall (each a director and executive officer, North Vancouver, British Columbia, Canada), and Ammad Shorbaji and Janette Lyons (each an executive officer, North Vancouver, British Columbia, Canada). Filing: https://www.sec.gov/Archives/edgar/data/1916630/000091228226001352/0000912282-26-001352-index.htm
This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Form D 2026 | 2026-10-09 | $120K |
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/1916630/000091228226001352/0000912282-26-001352-index.htm
Type: sec filing. Accessed 2026-10-14.
SEC Form D for Andira Medicine Inc. Signed 2026-10-09. EDGAR filing date 2026-10-09. First sale 2026-09-24. Total offering amount $120,000, all of it sold. Issuer address city is North Vancouver, British Columbia, Canada. Jurisdiction of incorporation is British Columbia, Canada. One investor already invested. The form does not name that investor or a round type. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-13/
Type: other verified public source. Accessed 2026-10-14.
Raise Track Update for 2026-10-13, Section 3 (SEC Form D filings). Lists Andira Medicine, state BRITISH COLUMBIA, CANADA, industry Other, amount raised $120,000.